Clinical Trial

Intrathecal Morphine 75 mcg Versus 100 mcg for Post-Cesarean Analgesia: A Randomized Double-blind Trial

Study acronym: ITM-CESAREAN
Completed Phase 4
View on ClinicalTrials.gov →
Summary
This study evaluates the efficacy and safety of two different doses of intrathecal morphine (75 mcg versus 100 mcg) for postoperative analgesia in patients undergoing elective cesarean delivery under spinal anesthesia. Effective postoperative pain control is essential to improve maternal recovery, facilitate early mobilization, and enhance neonatal care. Participants were randomly of assigned to receive either 75 mcg or 100 mcg of intrathecal morphine dose that provides effective analgesia while minimizing adverse effects in the obstetric population.
Trial Details
NCT Number NCT07516717
Lead Sponsor Hospital Universitario de Caracas
Conditions Postoperative Pain, Cesarean Section, Obstetric Anesthesia
Enrollment 240 participants
Start Date 2023-01-07
Primary Completion 2024-06-15 (estimated)
Study Completion 2024-07-17 (estimated)
Updated on ClinicalTrials.gov 2026-04-08